Market cap
₹15 Cr
Recently Viewed
Clear AllBSE: 543520
₹14.05
₹-0.06
(-0.43%)
As on 28-Apr-2026IST
Market cap
₹15 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
74.2
P/B Ratio
0.6
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
0.8 %
ROCE
1.3 %
Industry P/E
395.23
EV/EBITDA
-7.7
Debt to Equity
0
Book Value
₹23.8
EPS
₹0.2
Face value
10
Shares outstanding
10,500,000
CFO
₹-7.57 Cr
EBITDA
₹23.43 Cr
Net Profit
₹5.96 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Global Longlife
| -44.4 | 0.2 | -25.5 | -37.6 | -33.5 | -- | -- |
|
BSE Healthcare
| 2.6 | 5.0 | 8.0 | 6.4 | 25.0 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Global Longlife
| -19.2 | -26.2 | -23.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Global Longlife
|
14.1 | 14.8 | 0.6 | 0.2 | -- | 0.8 | 74.2 | 0.6 |
| 63.5 | 65.4 | 24.2 | 1.5 | 5.5 | 11 | 44.6 | 5.1 | |
| 705.3 | 36,540.5 | 4,461.2 | 397.5 | 13.4 | 9.1 | 111.7 | 7.9 | |
| 9.4 | 8.1 | 4.5 | 0.4 | -- | 4.3 | 19.4 | 0.6 | |
| 1,411.7 | 23,668.0 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.8 | 9.2 | |
| 662.3 | 26,529.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.2 | 11.4 | |
| 120.2 | 249.4 | 51.6 | 0.7 | 1.3 | 1.1 | 381.8 | 4.1 | |
| 127.0 | 42.6 | 16.5 | -1.4 | 6.6 | -3.6 | -- | 1.1 | |
| 17.2 | 39.1 | 0.0 | -8.7 | -- | -64.3 | -- | 3.4 | |
| 70.2 | 30.0 | 27.2 | -2.0 | -3.4 | -287.5 | -- | -28.7 |
No Review & Analysis are available.
Hospital activities
Incorporated
2012
Chairman
--
Managing Director
Dhruv Sureshkumar Jani
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Global Longlife Hospital and Research Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Global Longlife Hospital and Research Ltd is ₹14.05 (BSE) as of 28-Apr-2026 IST. Global Longlife Hospital and Research Ltd has given a return of -33.51% in the last 3 years.
The P/E ratio of Global Longlife Hospital and Research Ltd is 74.25 times as on 28-Apr-2026, a 81 discount to its peers’ median range of 395.23 times.
The P/B ratio of Global Longlife Hospital and Research Ltd is 0.59 times as on 28-Apr-2026, a 83 discount to its peers’ median range of 3.40 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
100.19
|
0.80
|
|
2024
|
0.00
|
1.73
|
|
2023
|
25.73
|
0.76
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Global Longlife Hospital and Research Ltd are Rs 33.02 and Rs 11.60 as of 28-Apr-2026.
Global Longlife Hospital and Research Ltd has a market capitalisation of ₹ 15 Cr as on 28-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Global Longlife Hospital and Research Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.